Common Contracts
26 similar At-the-Market Issuance Sales Agreement contracts by ENDRA Life Sciences Inc., DPW Holdings, Inc., Alzamend Neuro, Inc., others
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • October 25th, 2024 • RDE, Inc. • Retail-catalog & mail-order houses • New York
RDE, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • October 3rd, 2024 • Alzamend Neuro, Inc. • Pharmaceutical preparations • New York
Alzamend Neuro, Inc., a Delaware corporation (the Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • September 24th, 2024 • Aclarion, Inc. • Services-medical laboratories • New York
Aclarion, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • August 9th, 2024 • Oragenics Inc • Pharmaceutical preparations • New York
Oragenics, Inc., a Florida corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • July 12th, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • June 27th, 2024 • Singing Machine Co Inc • Phonograph records & prerecorded audio tapes & disks • New York
The Singing Machine Company, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • May 17th, 2024 • Duos Technologies Group, Inc. • Services-prepackaged software • New York
Duos Technologies Group, Inc., a Florida corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • March 20th, 2024 • Allarity Therapeutics, Inc. • Pharmaceutical preparations • New York
Allarity Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
ENDRA LIFE SCIENCES INC. Common Stock (par value $0.0001 per share) At-The- Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • February 14th, 2024 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC and the other sales agents set forth on Annex 1 hereto (each, an “Agent” and, collectively, the “Agents”), as follows:
VERB TECHNOLOGY COMPANY, INC. Common Stock (par value $0.0001 per share) At- The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • December 15th, 2023 • Verb Technology Company, Inc. • Services-personal services • New York
Verb Technology Company, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
BIOSIG TECHNOLOGIES, INC. Common Stock (par value $0.001 per share) At-The- Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • September 15th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
BioSig Technologies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • September 8th, 2023 • Alzamend Neuro, Inc. • Pharmaceutical preparations • New York
Alzamend Neuro, Inc., a Delaware corporation (the Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • August 21st, 2023 • Society Pass Incorporated. • Services-business services, nec • New York
Society Pass Incorporated, a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • June 9th, 2023 • Ault Alliance, Inc. • Electronic components, nec • New York
Ault Alliance, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (“Ascendiant”), as follows:
Common Stock (par value $0.01 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • February 17th, 2023 • Singing Machine Co Inc • Phonograph records & prerecorded audio tapes & disks • New York
The Singing Machine Company, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Aegis Capital Corp. (“Aegis”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • January 24th, 2023 • Ecoark Holdings, Inc. • Crude petroleum & natural gas • New York
Ecoark Holdings, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • August 20th, 2021 • Verb Technology Company, Inc. • Services-personal services • New York
Verb Technology Company, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Truist Securities, Inc. (the “Agent”), as follows:
ExENDRA LIFE SCIENCES INC. Common Stock (par value $0.0001 per share) At-The- Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • June 21st, 2021 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC and the other sales agents set forth on Annex 1 hereto (each, an “Agent” and, collectively, the “Agents”), as follows:
ENDRA LIFE SCIENCES INC. Common Stock (par value $0.0001 per share) At-The- Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • February 19th, 2021 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC and the other sales agents set forth on Annex 1 hereto (each, an “Agent” and, collectively, the “Agents”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • January 25th, 2021 • Ault Global Holdings, Inc. • Electronic components, nec • New York
Ault Global Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (“Ascendiant”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • October 5th, 2020 • IMAC Holdings, Inc. • Services-specialty outpatient facilities, nec • New York
IMAC Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (“Ascendiant”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • October 2nd, 2020 • DPW Holdings, Inc. • Electronic components, nec • New York
DPW Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (“Ascendiant”), as follows:
ENDRA LIFE SCIENCES INC. Common Stock (par value $0.0001 per share) At-The- Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • September 25th, 2020 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC and the other sales agents set forth on Annex 1 hereto (each, an “Agent” and, collectively, the “Agents”), as follows:
PHUNWARE, INC. Common Stock (par value $0.0001 per share) At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • August 14th, 2020 • Phunware, Inc. • Services-computer processing & data preparation • New York
Phunware, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (“Ascendiant”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • August 6th, 2019 • DPW Holdings, Inc. • Electronic components, nec • New York
DPW Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (“Ascendiant”), as follows:
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • October 16th, 2018 • DPW Holdings, Inc. • Electronic components, nec • New York
